TERT and liver cancer: Using cultured human liver cancer cells and vertebrate HCC models will be critical for confirming that the mechanism of TERT/β-catenin interaction identified in stem cells applies to HCC and establishing that non-canonical effects of TERT drive its interactions with β-catenin and the resulting HCC-promoting effects.